title: Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in RA patients: response to Mokuda.
authors.affiliation: Department of Orthopaedic Surgery, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, 565-0871, Osaka, Japan, k-ebina@umin.ac.jp.
authors.forename: K
authors.initials: K
authors.lastname: Ebina
authors.forename: J
authors.initials: J
authors.lastname: Hashimoto
authors.forename: K
authors.initials: K
authors.lastname: Shi
authors.forename: M
authors.initials: M
authors.lastname: Kashii
authors.forename: M
authors.initials: M
authors.lastname: Hirao
authors.forename: H
authors.initials: H
authors.lastname: Yoshikawa
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D019379:Teriparatide / Q000008:administration & dosage*
chemical_list: D050071:Bone Density Conservation Agents; D019379:Teriparatide